Search Results - Andrea Navarria
- Showing 1 - 8 results of 8
-
1
-
2
-
3
-
4
-
5
-
6
Scopolamine Rapidly Increases Mammalian Target of Rapamycin Complex 1 Signaling, Synaptogenesis, and Antidepressant Behavioral Responses by Bhavya Voleti, Andrea Navarria, Rong-Jian Liu, Mounira Banasr, Nanxin Li, Rose Z. Terwilliger, Gerard Sanacora, Tore Eid, George K. Aghajanian, Ronald S. Duman
Published 2013Artigo -
7
Rapid antidepressant actions of scopolamine: Role of medial prefrontal cortex and M1-subtype muscarinic acetylcholine receptors by Andrea Navarria, Eric S. Wohleb, Bhavya Voleti, Kristie T. Ota, Sophie Dutheil, Ashley E. Lepack, Jason M. Dwyer, Manabu Fuchikami, Astrid Becker, Filippo Drago, Ronald S. Duman
Published 2015Artigo -
8
Dose-response, efficacy, and safety of oral semaglutide monotherapy in Japanese patients with type 2 diabetes (PIONEER 9): a 52-week, phase 2/3a, randomised, controlled trial by Yuichiro Yamada, Hideki Katagiri, Yoshiyuki Hamamoto, Srikanth Deenadayalan, Andrea Navarria, Keiji Nishijima, Yutaka Seino, Yasushi Fukushima, Yoshiyuki Hamamoto, Hisatomi Arima, Yumiko Ide, Satoshi Inoue, Tatsushi Kawada, H Kim, Arihiro Kiyosue, K Matoba, Osamu Matsuoka, H. Nishimura, Masahiro Noguchi, Takeshi Osonoi, Shojiro Sawada, Yoshiyuki Shibasaki, Koki Shin, Yuichiro Yamada
Published 2020Artigo
Search Tools:
Related Subjects
Medicine
Diabetes mellitus
Endocrinology
Internal medicine
Type 2 diabetes
Liraglutide
Pharmacology
Semaglutide
Adverse effect
Dulaglutide
Oral administration
Pharmacokinetics
Alternative medicine
Antagonist
Biology
Environmental health
Neuroscience
Pathology
Placebo
Population
Receptor
Acetylcholine
Anthropology
Antidepressant
Bioavailability
Biochemistry
Body weight
Cell biology
Cholinergic
Clinical endpoint